NCT01454843

Brief Summary

The purpose of the study is to compare the results of LASIK surgery when using Alcon Allegretto wavefront-guided excimer laser system compared to AMO Visx Custom wavefront-guided excimer laser system in patients with nearsightedness with and without astigmatism.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Apr 2009

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2009

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2011

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

October 6, 2011

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 19, 2011

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 23, 2012

Completed
Last Updated

April 11, 2022

Status Verified

April 1, 2022

Enrollment Period

2 years

First QC Date

October 6, 2011

Last Update Submit

April 3, 2022

Conditions

Keywords

MyopiaAstigmatismAberrationsWavefrontLASIKWavefront LASIK

Outcome Measures

Primary Outcomes (1)

  • Efficacy

    Efficacy measures uncorrected visual acuity following the LASIK surgery. We will record how many eyes see 20/40, 20/30, 20/25, 20/20, 20/16, 20/12.5 and 20/10 after the surgery without glasses or contact lenses. We are measuring how well patients see after the surgery without glasses or contact lenses.

    1 year

Secondary Outcomes (4)

  • Low contrast visual acuity

    1 year

  • Higher order aberrations

    1 year

  • Safety

    One year

  • Predictability

    One year

Study Arms (2)

Wavefront-guided LASIK - Allegretto

ACTIVE COMPARATOR

Wavefront-guided LASIK using the Allegretto excimer laser.

Procedure: Wavefront-guided LASIK - Allegretto

Wavefront-guided LASIK - AMO

ACTIVE COMPARATOR

Wavefront-guided LASIK using AMO CustomVue excimer laser.

Procedure: Wavefront-guided LASIK - AMO

Interventions

Wavefront-guided LASIK using the Allegretto excimer laser for myopia.

Also known as: Alcon Wavelight Allegretto Eye-Q 400 Hz excimer laser
Wavefront-guided LASIK - Allegretto

Wavefront-guided LASIK using the AMO CustomVue excimer laser for myopia.

Also known as: AMO Visx CustomVue S4 IR excimer laser
Wavefront-guided LASIK - AMO

Eligibility Criteria

Age21 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Subjects age 21 and older with healthy eyes.
  • Nearsightedness between -0.50 diopters and -7.00 diopters with or without astigmatism of up to 3.50 diopters.

You may not qualify if:

  • Subjects under the age of 21.
  • Patients with excessively thin corneas.
  • Patients with topographic evidence of keratoconus.
  • Patients with ectatic eye disorders.
  • Patients with autoimmune diseases.
  • Patients who are pregnant or nursing.
  • Patients must have similar levels of nearsightedness with or without astigmatism in each eye.
  • They can not be more than 1.5 diopters of difference between eyes.
  • Patients must have similar levels of astigmatism in each eye.
  • They can not have more than 1.5 diopters of difference in nearsightedness or astigmatism between their two eyes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Byers Eye Institute at Stanford

Palo Alto, California, 94303, United States

Location

Related Publications (6)

  • He L, Manche EE. Contralateral eye-to-eye comparison of wavefront-guided and wavefront-optimized photorefractive keratectomy: a randomized clinical trial. JAMA Ophthalmol. 2015 Jan;133(1):51-9. doi: 10.1001/jamaophthalmol.2014.3876.

    PMID: 25321951BACKGROUND
  • He L, Manche EE. Prospective randomized contralateral eye evaluation of subjective quality of vision after wavefront-guided or wavefront- optimized photorefractive keratectomy. J Refract Surg. 2014 Jan;30(1):6-12. doi: 10.3928/1081597X-20131217-01.

    PMID: 24868564BACKGROUND
  • Lee WS, Manche EE. Comparison of simulated keratometric changes following wavefront-guided and wavefront-optimized myopic laser-assisted in situ keratomileusis. Clin Ophthalmol. 2018 Mar 29;12:613-619. doi: 10.2147/OPTH.S161387. eCollection 2018.

    PMID: 29636597BACKGROUND
  • He L, Liu A, Manche EE. Wavefront-guided versus wavefront-optimized laser in situ keratomileusis for patients with myopia: a prospective randomized contralateral eye study. Am J Ophthalmol. 2014 Jun;157(6):1170-1178.e1. doi: 10.1016/j.ajo.2014.02.037. Epub 2014 Feb 19.

    PMID: 24560995BACKGROUND
  • Sales CS, Manche EE. One-year outcomes from a prospective, randomized, eye-to-eye comparison of wavefront-guided and wavefront-optimized LASIK in myopes. Ophthalmology. 2013 Dec;120(12):2396-2402. doi: 10.1016/j.ophtha.2013.05.010. Epub 2013 Jun 15.

    PMID: 23778091BACKGROUND
  • Sales CS, Manche EE. One-year eye-to-eye comparison of wavefront-guided versus wavefront-optimized laser in situ keratomileusis in hyperopes. Clin Ophthalmol. 2014 Nov 12;8:2229-38. doi: 10.2147/OPTH.S70145. eCollection 2014.

    PMID: 25419115BACKGROUND

MeSH Terms

Conditions

MyopiaAstigmatism

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Officials

  • Edward E Manche, MD

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Ophthalmology

Study Record Dates

First Submitted

October 6, 2011

First Posted

October 19, 2011

Study Start

April 1, 2009

Primary Completion

March 31, 2011

Study Completion

June 23, 2012

Last Updated

April 11, 2022

Record last verified: 2022-04

Locations